Angiotensin I-converting enzyme gene polymorphism and drug response.
about
Predicting drug-target interaction networks based on functional groups and biological featuresAngiotensin II receptor polymorphisms in hypertension. Pharmacogenomic considerations.New aspects on angiotensin-converting enzyme: from gene to disease.Nutritional genomicsHypokalemia, its contributing factors and renal outcomes in patients with chronic kidney disease.Pharmacogenomics of primary hypertension--the lessons from the past to look toward the future.Polymorphism in angiotensin II receptor genes and hypertension.Polymorphisms of the renin-angiotensin system are associated with blood pressure, atherosclerosis and cerebral white matter pathology.Pharmacogenetics approach to therapeutics.The genetic determinants of renal impairment following cardiac surgery.Pharmacogenomics and nutrigenomics: synergies and differences.Associations between the insertion/deletion polymorphism of the angiotensin-converting enzyme and susceptibility to aortic aneurysms: A meta-analysis.Associations between the angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to sarcoidosis: A meta-analysis.Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome.Correlation of Angiotensin-converting enzyme gene polymorphism with effect of antihypertensive therapy by Angiotensin-converting enzyme inhibitor.Gene expression profiling of the short-term adaptive response to acute caloric restriction in liver and adipose tissues of pigs differing in feed efficiency.Interaction between GNB3 C825T and ACE I/D polymorphisms in essential hypertension in Koreans.
P2860
Q28473160-57ABD32C-7436-49E4-8052-CF8370396B80Q34609146-92DFB799-26DA-4DB6-B3A9-C3D28CC0A170Q34634309-CA96FA71-F2F4-4971-9DA5-56955ABBC1F1Q34686551-CF8FF0CD-38FF-4838-9F23-92EA30DD1281Q34812460-71E1298D-E3DA-4BA6-8096-CCA90CE534D9Q35116095-FC1D98CF-F9A7-42C5-A338-5A945EB3741CQ36003958-A6F602D6-9F36-4634-8BBE-0EE035D22F36Q36226659-43096360-0188-4289-8962-A29F3141F3BDQ36478845-CF2DE217-F3DE-4447-B0FD-40E9D8BC6ACEQ36697914-23324A25-D4F3-4DF1-8E37-85639FB7007DQ36703598-CC7E5D8F-13E6-404C-A57C-2E3057B369C7Q38099097-394CAEB3-566C-43AB-B58F-68FDBD8BF144Q38107039-2F6EDF25-742C-4EEF-B175-4A1641C40973Q40133099-A5B26747-88DB-419C-B43B-1938A5C56B2FQ44372598-0F7209B8-3303-460A-971C-0BF31F7AF8E9Q53358080-7F788507-D660-4DA7-A859-2114C90C5A9EQ53585869-88E44BA1-C530-491D-8C9D-21956B00F90A
P2860
Angiotensin I-converting enzyme gene polymorphism and drug response.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Angiotensin I-converting enzyme gene polymorphism and drug response.
@ast
Angiotensin I-converting enzyme gene polymorphism and drug response.
@en
Angiotensin I-converting enzyme gene polymorphism and drug response.
@nl
type
label
Angiotensin I-converting enzyme gene polymorphism and drug response.
@ast
Angiotensin I-converting enzyme gene polymorphism and drug response.
@en
Angiotensin I-converting enzyme gene polymorphism and drug response.
@nl
prefLabel
Angiotensin I-converting enzyme gene polymorphism and drug response.
@ast
Angiotensin I-converting enzyme gene polymorphism and drug response.
@en
Angiotensin I-converting enzyme gene polymorphism and drug response.
@nl
P2860
P356
P1476
Angiotensin I-converting enzyme gene polymorphism and drug response.
@en
P2093
P2860
P304
P356
10.1515/CCLM.2000.123
P577
2000-09-01T00:00:00Z